Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

Luigia Luciano, Roberto Latagliata, Gabriele Gugliotta, Mario Annunziata, Mario Tiribelli, Bruno Martino, Antonello Sica, Maria Rosaria Esposito, Monica Bocchia, Sara Galimberti, Federica Sora', Francesco Albano, Raffaele Palmieri, Patrizia Pregno, Matteo Dragani, Maria Iovine, Simona Sica, Alessandra Iurlo, Fausto Castagnetti, Gianantonio RostiMassimo Breccia

Research output: Contribution to journal › Article

Fingerprint

Dive into the research topics of 'Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science